BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19739125)

  • 1. Modifying the conserved C-terminal tyrosine of the peptide hormone PYY3-36 to improve Y2 receptor selectivity.
    Pedersen SL; Holst B; Vrang N; Jensen KJ
    J Pept Sci; 2009 Nov; 15(11):753-9. PubMed ID: 19739125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyco-scan: varying glycosylation in the sequence of the peptide hormone PYY3-36 and its effect on receptor selectivity.
    Pedersen SL; Steentoft C; Vrang N; Jensen KJ
    Chembiochem; 2010 Feb; 11(3):366-74. PubMed ID: 20049760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide architecture: adding an alpha-helix to the PYY lysine side chain provides nanomolar binding and body-weight-lowering effects.
    Pedersen SL; Sasikumar PG; Vrang N; Jensen KJ
    ChemMedChem; 2010 Apr; 5(4):545-51. PubMed ID: 20183851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice.
    Pedersen SL; Sasikumar PG; Chelur S; Holst B; Artmann A; Jensen KJ; Vrang N
    J Pept Sci; 2010 Nov; 16(11):664-73. PubMed ID: 20853314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
    Akerberg H; Fällmar H; Sjödin P; Boukharta L; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Regul Pept; 2010 Aug; 163(1-3):120-9. PubMed ID: 20471432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
    Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
    Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteolytic processing by dipeptidyl aminopeptidase IV generates receptor selectivity for peptide YY (PYY)].
    Grandt D; Dahms P; Schimiczek M; Eysselein VE; Reeve JR; Mentlein R
    Med Klin (Munich); 1993 Mar; 88(3):143-5. PubMed ID: 8097274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PP-fold solution structure of human polypeptide YY and human PYY3-36 as determined by NMR.
    Nygaard R; Nielbo S; Schwartz TW; Poulsen FM
    Biochemistry; 2006 Jul; 45(27):8350-7. PubMed ID: 16819834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A parallel semisynthetic approach for structure-activity relationship studies of peptide YY.
    Albertsen L; Østergaard S; Paulsson JF; Norrild JC; Strømgaard K
    ChemMedChem; 2013 Sep; 8(9):1505-13, 1422. PubMed ID: 23907926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of selective neuropeptide Y2 peptide agonists.
    DeCarr LB; Buckholz TM; Coish PD; Fathi Z; Fisk SE; Mays MR; O'Connor SJ; Lumb KJ
    Bioorg Med Chem Lett; 2007 Jan; 17(2):538-41. PubMed ID: 17055726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving membrane binding as a design strategy for amphipathic peptide hormones: 2-helix variants of PYY3-36.
    Pedersen SL; Bhatia VK; Jurt S; Paulsson JF; Pedersen MH; Jorgensen R; Holst B; Stamou D; Vrang N; Zerbe O; Jensen KJ
    J Pept Sci; 2012 Sep; 18(9):579-87. PubMed ID: 22865741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
    Lerch M; Mayrhofer M; Zerbe O
    J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of Y
    Østergaard S; Kofoed J; Paulsson JF; Madsen KG; Jorgensen R; Wulff BS
    J Med Chem; 2018 Dec; 61(23):10519-10530. PubMed ID: 30399314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y1-receptors regulate the expression of Y2-receptors in distinct mouse forebrain areas.
    Wittmann W; Loacker S; Kapeller I; Herzog H; Schwarzer C
    Neuroscience; 2005; 136(1):241-50. PubMed ID: 16198492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
    Gehlert DR; Shaw JL
    Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenesis and computational modeling of human G-protein-coupled receptor Y2 for neuropeptide Y and peptide YY.
    Xu B; Fällmar H; Boukharta L; Pruner J; Lundell I; Mohell N; Gutiérrez-de-Terán H; Aqvist J; Larhammar D
    Biochemistry; 2013 Nov; 52(45):7987-98. PubMed ID: 24111902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.
    Lumb KJ; DeCarr LB; Milardo LF; Mays MR; Buckholz TM; Fisk SE; Pellegrino CM; Ortiz AA; Mahle CD
    J Med Chem; 2007 May; 50(9):2264-8. PubMed ID: 17425299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Development of Stable PYY
    Poulsen C; Pedersen MØ; Wahlund PO; Sjölander A; Thomsen JK; Conde-Frieboes KW; Paulsson JF; Wulff BS; Østergaard S
    Pharm Res; 2021 Aug; 38(8):1369-1385. PubMed ID: 34272643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.